AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JP who wrote (1319)	4/14/1998 1:42:00 AM
From: D.Right	Read Replies (1) of 2173

More reasons: 1. Good clinical data. (not likely, too early for that.) 2. Deal. (most likely, they do need money, period.) 3. Possible, just possible that there are new indications for parmlintide for other diseases such as heart problems in animal models (remember, it has lowered cholesterol in last trial III). Enjoy the first turn in a long while for better days ahead, everyone. D.Right

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next